Chapter
Clips
John Bolton was an odd choice for Trump as he went against the anti-interventionist stance that won Trump the Republican nomination.
59:35 - 1:00:44 (01:09)
Summary
John Bolton was an odd choice for Trump as he went against the anti-interventionist stance that won Trump the Republican nomination. Bolton is a hawkish figure who supports involvement in wars and conflicts, even with Iran.
ChapterUnknown Vaccine Sponsorship
EpisodeE4: Politicizing the pandemic, Police reform, Biden's ideal VP, Twitter vs. Facebook on free speech & more with David Sacks & David Friedberg
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The speaker believes that John Bolton is a "crazy warhawk" who also has a weasel-like personality, choosing TV personalities for his team, and prioritizing his book over the future of the country.
1:00:44 - 1:02:15 (01:31)
Summary
The speaker believes that John Bolton is a "crazy warhawk" who also has a weasel-like personality, choosing TV personalities for his team, and prioritizing his book over the future of the country.
ChapterUnknown Vaccine Sponsorship
EpisodeE4: Politicizing the pandemic, Police reform, Biden's ideal VP, Twitter vs. Facebook on free speech & more with David Sacks & David Friedberg
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The discussion ranges from the production of vaccines to parenting expectations, with a focus on the low expectations people have for both.
1:02:16 - 1:06:15 (03:59)
Summary
The discussion ranges from the production of vaccines to parenting expectations, with a focus on the low expectations people have for both.
ChapterUnknown Vaccine Sponsorship
EpisodeE4: Politicizing the pandemic, Police reform, Biden's ideal VP, Twitter vs. Facebook on free speech & more with David Sacks & David Friedberg
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The uncertain stance of the US President, Donald Trump, and the incidents of civil unrest could potentially impact the future of pharmaceutical companies.
1:06:16 - 1:09:03 (02:46)
Summary
The uncertain stance of the US President, Donald Trump, and the incidents of civil unrest could potentially impact the future of pharmaceutical companies. Although the ones receiving federal aid will be subjected to the dictum of distribution, the COVID pandemic has dented Trump's reputation that was initially built on his economy successes.